BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 29752871)

  • 21. The GTPase Rac regulates the proliferation and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.
    Chan A; Akhtar M; Brenner M; Zheng Y; Gulko PS; Symons M
    Mol Med; 2007; 13(5-6):297-304. PubMed ID: 17622308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Targeting the Actin Cytoskeleton Potentiates the Cytotoxicity of Low Dose Vincristine by Abrogating Actin-Mediated Repair of Spindle Defects.
    Wang Y; Stear JH; Swain A; Xu X; Bryce NS; Carnell M; Alieva IB; Dugina VB; Cripe TP; Stehn J; Hardeman EC; Gunning PW
    Mol Cancer Res; 2020 Jul; 18(7):1074-1087. PubMed ID: 32269073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma.
    Penter L; Maier B; Frede U; Hackner B; Carell T; Hagemeier C; Truss M
    Target Oncol; 2015 Dec; 10(4):523-33. PubMed ID: 25559288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX.
    Filipenko NR; Attwell S; Roskelley C; Dedhar S
    Oncogene; 2005 Sep; 24(38):5837-49. PubMed ID: 15897874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.
    Akkari PA; Song Y; Hitchcock-DeGregori S; Blechynden L; Laing N
    Biochem Biophys Res Commun; 2002 Aug; 296(2):300-4. PubMed ID: 12163017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells.
    Stehn JR; Haass NK; Bonello T; Desouza M; Kottyan G; Treutlein H; Zeng J; Nascimento PR; Sequeira VB; Butler TL; Allanson M; Fath T; Hill TA; McCluskey A; Schevzov G; Palmer SJ; Hardeman EC; Winlaw D; Reeve VE; Dixon I; Weninger W; Cripe TP; Gunning PW
    Cancer Res; 2013 Aug; 73(16):5169-82. PubMed ID: 23946473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth.
    Chuang JH; Chou MH; Tai MH; Lin TK; Liou CW; Chen T; Hsu WM; Wang PW
    Int J Biochem Cell Biol; 2013 May; 45(5):944-51. PubMed ID: 23395630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.
    Fabian J; Opitz D; Althoff K; Lodrini M; Hero B; Volland R; Beckers A; de Preter K; Decock A; Patil N; Abba M; Kopp-Schneider A; Astrahantseff K; Wünschel J; Pfeil S; Ercu M; Künkele A; Hu J; Thole T; Schweizer L; Mechtersheimer G; Carter D; Cheung BB; Popanda O; von Deimling A; Koster J; Versteeg R; Schwab M; Marshall GM; Speleman F; Erb U; Zoeller M; Allgayer H; Simon T; Fischer M; Kulozik AE; Eggert A; Witt O; Schulte JH; Deubzer HE
    Oncotarget; 2016 Oct; 7(41):66344-66359. PubMed ID: 27572323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Al-Ghabkari A; Narendran A
    Cancer Biother Radiopharm; 2019 May; 34(4):252-257. PubMed ID: 30724592
    [No Abstract]   [Full Text] [Related]  

  • 31. Stabilization of F-actin by tropomyosin isoforms regulates the morphology and mechanical behavior of red blood cells.
    Sui Z; Gokhin DS; Nowak RB; Guo X; An X; Fowler VM
    Mol Biol Cell; 2017 Sep; 28(19):2531-2542. PubMed ID: 28720661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INSM1 increases N-myc stability and oncogenesis via a positive-feedback loop in neuroblastoma.
    Chen C; Breslin MB; Lan MS
    Oncotarget; 2015 Nov; 6(34):36700-12. PubMed ID: 26456864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.
    Häbig K; Gellhaar S; Heim B; Djuric V; Giesert F; Wurst W; Walter C; Hentrich T; Riess O; Bonin M
    Biochim Biophys Acta; 2013 Dec; 1832(12):2352-67. PubMed ID: 24075941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nischarin inhibits Rac induced migration and invasion of epithelial cells by affecting signaling cascades involving PAK.
    Alahari SK
    Exp Cell Res; 2003 Aug; 288(2):415-24. PubMed ID: 12915132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling.
    Jeong S; Lim S; Schevzov G; Gunning PW; Helfman DM
    Oncotarget; 2017 May; 8(20):33544-33559. PubMed ID: 28431393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NEDD9 regulates 3D migratory activity independent of the Rac1 morphology switch in glioma and neuroblastoma.
    Zhong J; Bach CT; Shum MS; O'Neill GM
    Mol Cancer Res; 2014 Feb; 12(2):264-73. PubMed ID: 24337070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tropomyosin Isoforms Specify Functionally Distinct Actin Filament Populations In Vitro.
    Gateva G; Kremneva E; Reindl T; Kotila T; Kogan K; Gressin L; Gunning PW; Manstein DJ; Michelot A; Lappalainen P
    Curr Biol; 2017 Mar; 27(5):705-713. PubMed ID: 28216317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norcantharidin enhances ABT-263-mediated anticancer activity in neuroblastoma cells by upregulation of Noxa.
    Wang X; Gu Z; Li G; Zhang S; Cao Z; Yang Z; Liu G
    Oncol Rep; 2014 Aug; 32(2):716-22. PubMed ID: 24891300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
    Azios NG; Krishnamoorthy L; Harris M; Cubano LA; Cammer M; Dharmawardhane SF
    Neoplasia; 2007 Feb; 9(2):147-58. PubMed ID: 17356711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.